Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
38.65
-0.46 (-1.18%)
Dec 20, 2024, 4:00 PM EST - Market closed

Bright Minds Biosciences Analyst Ratings

Total Analysts
1
Consensus Rating
Buy
Price Target
$75.00
Upside
+94.05%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Baird
Baird
Buy
Initiates
$75
Buy Initiates $75 +94.05% Nov 25, 2024